Vaccine against Omicron variant expected to be available in 2022
BioNTech SE and Pfizer Inc. are working together on an effective vaccine against the Omicron variant of the coronavirus. These companies promise to present the finished product by March 2022. According to a press release on the website of the American pharmaceutical company, the serum antibodies produced by the Pfizer-BioNTech vaccine will neutralize this new…
